ライフサイエンスコーパス: receive

1 assigned patients according to the treatment received.

2 was 16.2 (range 0-30); 5.1 (range 0-15) were received.

3 he thermal transients for the next bit to be received.

4 H and the composition of the applications it receives.

5 diet the subjects were randomly assigned to receive 1 of the following 3 interventions daily for 5 w

6 he UK National Mycology Reference Laboratory received 1,267 serum and respiratory samples from 719 cr

7 h OSA with low-to-moderate arousal threshold received 10 mg zolpidem or placebo according to a double

8 re randomly assigned with 50% probability to receive 12 Clearblue visual HPTs plus the standard proto

9 13 with genotype 4; 166 with genotype 6) who received 12 to 24 weeks of daclatasvir plus sofosbuvir (

10 f these, 197 (34%) were randomly assigned to receive 150 mg S44819 twice a day, 195 (33%) to receive

11 Patients received 174 +/- 28 MBq of the radiotracer, which was we

12 One hundred forty-five patients received 197 courses of ISA prophylaxis.

13 (18-55 years of age), who were randomized to receive 2 doses-separated by 21 days-of 10 mug, 30 mug o

14 Participants were randomized 1:1 to receive 2 intramuscular injections 28 days apart (20 ug,

15 Patients were randomized 1:1 to receive 25 mg clazakizumab or placebo (4-weekly subcutan

16 mo postpartum who were randomly assigned to receive 3 treatments in a random order: bolus 30-g dose

17 eive 150 mg S44819 twice a day, 195 (33%) to receive 300 mg S44819 twice a day, and 193 (33%) to rece

18 f AEs was noted among patients aged >=50 who received 3HP-SAT (aRR 0.37 [0.16-0.85] p=0.02).

19 total of 170 participants were randomized to receive 6 monthly injections of either 1.25 mg bevacizum

20 Patients received 60 mg selinexor orally on days 1 and 3 weekly u

21 Nigeria received 7% ($1.1 billion) of all aid for RMNCH in 2017,

22 Study participants were randomized to receive 960 mg of oral co-trimoxazole twice daily (n = 1

23 ately 12 million adults in the United States receive a diagnosis of chronic obstructive pulmonary dis

24 oemulsification, eyes were randomized 2:1 to receive a Hydrus Microstent or no stent.

25 To date, ~50% of patients with bvFTD receive a prior psychiatric diagnosis, and average diagn

26 to vote for a Muslim (not on their team) to receive a sportsmanship award, register for a mixed team

27 f a potential recipient's transplant, and to receive a voucher that can be redeemed for a future tran

28 All hospitalized patients who received a blood culture during hospitalization.

29 8513 (32.8%) patients received a blood transfusion.

30 Patients received a conditioning regimen, infusion of donor hemat

31 Long Evans male rats received a controlled cortical impact (CCI) over the cau

32 imately 75% of clinical events when patients received a diagnosis of PSC at an age younger than 40 ye

33 younger than 40 years vs 31% of patients who received a diagnosis when older than 60 years (P < .001)

34 oup of 15.5 to 17 months of age C57BL/6 mice received a diet containing an Nrf2 inducer (Oltipraz) fo

35 Normand cull-cows received a diet enriched in n-3 polyunsaturated fatty ac

36 ic surgery between 2016 and 2018, 6114 (40%) received a first-generation cephalosporin, 4097 (27%) re

37 tions only, while the JADE (n = 9,601) group received a JADE report with group empowerment by nurses.

38 for graft failure in patients (n = 181) who received a kidney transplant in Olmsted County, MN (Janu

39 The control group received a leaflet with information on smoking cessation

40 Patients were grouped as having received a living donor liver allograft from either an o

41 Hamsters and African green monkeys received a primary intranasal infection with RSV and wer

42 a first-generation cephalosporin, 4097 (27%) received a second or third-generation cephalosporin, and

43 ith treatment-resistant depression (TRD) who received a single ketamine infusion (0.5 mg/kg) over 40

44 study period from 2008 to 2019 all patients receiving a decompression tube were identified by retros

45 del including baseline characteristics, only receiving a disability grant was significantly associate

46 receiving escalated dosing than among those receiving a fixed dose.

47 erosclerotic burden in miR-144 knockout mice receiving a high fat diet.

48 Nevertheless, this remains uncertain when receiving a kidney from a donor >=80 years old.

49 onal treatment (P = .005) or in patients who received abatacept or sirolimus as compared with other t

50 interactive voice or web response system to receive acalabrutinib and obinutuzumab, acalabrutinib mo

51 p to 60% of patients with malignancy who are receiving active treatment and up to 33% of patients dur

52 Patients receiving additional placement of cryopreserved AM had s

53 Controls and the microbicide-only group received adenovirus type 5 host range mutant empty vecto

54 S implantation and may prevent patients from receiving adequate pain treatment, adding to the initial

55 The experimental arm received adjuvant cetuximab.

56 13 (78%) without adjuvant therapy and 90 who received adjuvant chemotherapy with or without radiation

57 Patients received adjuvant therapy at physician's discretion.

58 Eyes receiving aflibercept showed a lower mean VA (mean diffe

59 ival was significantly superior for patients receiving aggregation inhibitors after LT.

60 at manifests when the stigma associated with receiving aid is countered and recipients are empowered,

61 Patients not receiving alemtuzumab (n=4) showed no UCART19 expansion

62 A total of 267 patients were assigned to receive allopurinol and 263 to receive placebo.

63 from prescriptions omitted affected children receiving alternative or no treatment and some antidepre

64 Vaccine recipients received ALVAC-HIV (vCP2438) alone at months 0 and 1 and

65 Between sessions, they received an expectancy manipulation (placebo or no-treat

66 Ninety-four eyes of 66 patients received an FAc implant.

67 rral center between 01/2016 and 07/2019, who received an infectious diseases consultation for an inva

68 nal PAR-2 activation and CGRP release, goats received an injection of 2,4,6-trinitro-benzenesulfonic-

69 nd anticipated antiretroviral susceptibility received an optimized regimen and were randomized to omi

70 ditis (cases, n = 101) to that from patients receiving an ICI who did not develop myocarditis (contro

71 Consecutive patients with nAMD received anti-VEGF therapy according to a T&E (n = 163)

72 HIV-related mortality between men and women receiving antiretroviral therapy (ART) is incompletely c

73 Children living with HIV (CLHIV) receiving antiretroviral treatment (ART) in resource lim

74 The safety population included patients who received any dose of study treatment.

75 of women with invasive cervical cancer would receive appropriate surgery, radiotherapy, and chemother

76 1.19; 95% CI, 1.06 to 1.34) and in those who received aprepitant or fosaprepitant.

77 DL4papers receives as input a query with the desired keywords, and

78 site 1 event occurred in 76 patients (23.0%) receiving aspirin alone and in 104 (31.1%) receiving asp

79 ) receiving aspirin alone and in 104 (31.1%) receiving aspirin plus clopidogrel (difference, -8.2 per

80 nts who met the eligibility criteria and who received at least 8 weeks of therapy.

81 by week 96, assessed in all participants who received at least one dose of any study drug, regardless

82 Safety was assessed in all participants who received at least one dose of study drug in terms of tre

83 Safety was assessed in all patients who received at least one dose of study drug.

84 All enrolled patients received at least one dose of study treatment and thus w

85 Safety was assessed in all patients who had received at least one dose of study treatment.

86 no prior diagnosis of bipolar disorder, who received at least one of the nine antidepressant medicat

87 tients with relapsed or refractory DLBCL who received at least two lines of previous chemoimmunothera

88 lood pressure lower than 150 mm Hg, and were receiving at least 2 antihypertensive medications were i

89 en did not have predictive value in patients receiving atezolizumab plus chemotherapy in the first-li

90 In contrast, HCV+ recipients who received ATG were at lower risk of acute rejection compa

91 nal cardiovascular health issues that should receive attention.

92 Engineering microrobots is increasingly receiving attention in this regard.

93 The trial enrolled 31 patients who received bendamustine on days 1 and 2 (100 mg/m(2) intra

94 Patients received bilateral dbPET and wbPET following administrat

95 15.0% at 48 hours (p = 0.0001) for patients receiving bilateral stimulation after excluding one pati

96 ird-generation cephalosporin, and 4971 (33%) received Broad-abx.

97 pathfinding behavior, but how this signal is received by epithelial cells is unknown.

98 HET mice receiving CAF (plasma CAF 893 ng/ml) have significantly

99 hsCRP and IL-6 decreased among participants receiving canakinumab compared with the placebo group.

100 117 had active malignancy, defined as those receiving cancer-directed therapy or under active survei

101 Center for AIDS Research HIV Clinical Cohort receiving care during 1996-2016, we estimated annual hos

102 at every hospital where the patient reported receiving care were acquired for adjudication, not just

103 Among patients who received chemoradiotherapy without surgery, combined ctD

104 Women who did not receive chemotherapy had a more than 97% rate of 8-year

105 sample proportions were done in all patients receiving CHOP or R-CHOP.

106 (part B), during which time all participants received clazakizumab.

107 Those receiving clazakizumab displayed significantly decreased

108 ts without hepatitis B virus co-infection to receive coformulated bictegravir 50 mg, emtricitabine 20

109 munosuppressive agents, and especially those receiving combination therapy, have an impaired immune r

110 an area of ceria defect chemistry which has received comparatively little attention - defect-induced

111 nuate acute kidney injury in transgenic mice receiving contrast material.

112 in patients who survived HSCT than in those receiving conventional treatment (P = .005) or in patien

113 8 matched patients, 209 received SoC and 209 received dalbavancin.

114 to last hour of EGP measurement) in subjects receiving dapagliflozin was 22% greater (+0.66 +/- 0.11

115 nce were significantly higher among patients receiving delamanid versus bedaquiline (36% vs 10%, resp

116 Patients were substantially more likely to receive devices made by the manufacturer that provided t

117 7 (2.8%) patients, 6 of whom had previously received DEX.

118 a of 28 503 randomly selected adult patients receiving dialysis in July, 2020, using a spike protein

119 used as control; T100, T200, and T300 groups received diets supplemented with 100, 200, and 300 mg/kg

120 well as fast-spiking inhibitory interneurons receive direct excitatory input from the intermediate/ve

121 A significantly higher proportion of women received DNR orders (35.7% versus 32.1%, P=0.009) and ha

122 corded on POD1 for 1285 (27.3%) patients who received drains.

123 e crossed over to the treatment they did not receive during the first treatment period, following whi

124 among other factors, by the amount of oxygen received during this process, which thus impacts its fin

125 In patients with COVID-19 who received ECMO, both estimated mortality 90 days after EC

126 nical trial, participants were randomized to receive either 150 mg/d of resveratrol (n = 20) or place

127 0 through 64 years of age were randomized to receive either a single dose of PCV20 followed 1 month l

128 ized 75 healthy, female, adult volunteers to receive either BCG, followed by a booster dose of tetanu

129 without end-organ failure in a 1:1 ratio to receive either LY-CoV555 or matching placebo.

130 who had or did not have brain metastases, to receive either tucatinib or placebo, in combination with

131 , 100 participants were randomly assigned to receive either vortioxetine or placebo in addition to co

132 jected daily with 5 mg/kg cyclosporine A and received either 10 mg/kg prednisolone (P), or LP intrave

133 a period of repeated training sessions, mice received either paired trials of a tone coterminating wi

134 All of them received either prophylactic entecavir or tenofovir ther

135 ated for an additional 48 hours and who were receiving enteral nutrition or expected to start imminen

136 Patients experiencing VIA received epinephrine less frequently than did cases with

137 ents were significantly lower among children receiving escalated dosing than among those receiving a

138 of 157 patients underwent randomization and received evolocumab (104 patients) or placebo (53 patien

139 before and after male rhesus macaque monkeys received extensive training to learn novel visuospatial

140 significantly worse OS and PFS than patients receiving first-line chemotherapy followed by resection.

141 on of Hg in the atmosphere as Mount Bachelor received free tropospheric air masses on certain nights

142 tal of 226 stool and 178 plasma samples were received from patients referred to colonoscopy units.

143 s derived using the electronic notifications received from the BCSP database to GP records.

144 the familial CDH1 mutation and subsequently received gastrectomy.

145 into the trial, and 302 entered the trial to receive genotype-matched therapy-including 14 that re-re

146 743 adults were enrolled; 741 received >=1 dose of study drug (DTG/3TC, N = 369; TAF-b

147 tal of 201 patients were randomized, and 199 received >=1 dose of study treatment.

148 different from 0; p=0.655) in those who had received >=15 doses (n=20).

149 rting of BL allergies, many patients may not receive guideline-directed cephalosporin-based prophylax

150 patients, those with UMI were less likely to receive guideline-directed medical therapies and present

151 The majority of the patients had received high-dose melphalan and stem cell transplantati

152 15 communities were randomly assigned to receive HIV prevention and treatment interventions, incl

153 erall outcome of patients with NLPHL who had received Hodgkin lymphoma-directed first-line treatment

154 We compared outcomes in patients who received hydroxychloroquine with those in patients who d

155 g bone loss) may be observed in patients who received IACS injections.

156 isk of acute rejection compared to those who received IL2RA (1-y crude incidence = 11.6% versus 12.6%

157 icial in the majority of IBD patients, those receiving immunosuppressive agents, and especially those

158 globes with the diagnosis of retinoblastoma received in the histopathology department(s) from Januar

159 en shown to have self-image costs: Those who receive incentives view their actions less positively du

160 these traded commodities, virtual water, has received increasing interest in the scientific community

161 All groups received individual counseling.

162 red in none of the 76 household contacts who received INH preventive therapy compared with 3% (8 of 2

163 did not.Conclusions: Household contacts who received INH preventive therapy had a lower incidence of

164 e explore brain nuclei that express Brn3c or receive input from Brn3c(+) neurons.

165 The basal forebrain (BF) receives inputs from many nuclei of the ascending arousa

166 These rats then received instrumental conditioning sessions where they c

167 Many Dalbergia species have received international attention for conservation, but t

168 Separate groups of rats received intra-NAc AAV2/5-CRF and saline IVSA.

169 participants were randomly assigned (1:1) to receive intramuscular fulvestrant 500 mg (day 1) every 2

170 ive voice-response or web-response system to receive intravenous durvalumab plus tremelimumab plus pl

171 -dose haloperidol, were randomly assigned to receive intravenous haloperidol dose escalation at 2 mg

172 Patients in the D-VMP group also received intravenous daratumumab (16 mg/kg of bodyweight

173 myosarcoma, and Ewing sarcoma, respectively) received IP (131)I-omburtamab administered on an outpati

174 iated by an inhA mutation were randomized to receive isoniazid 5, 10 or 15 mg/kg daily for 7 days (in

175 with antepartum haemorrhage who needed blood received it.

176 pansion, n = 9) with advanced chondrosarcoma received ivosidenib (women, n = 8; median age, 55 years;

177 and saliva samples from children and adults receiving LAIV prior to tonsillectomy.

178 yzed two independent cohorts of patients who received left prefrontal transcranial magnetic stimulati

179 5/23 received leronlimab after blinded placebo-controlled tri

180 other area of recent AI work that has so far received less attention from neuroscientists but that ma

181 their green-state photophysical behavior has received less attention.

182 hip between financial strain and suicide has received less attention.

183 tem cell and organ transplant recipients who received letermovir for the treatment of CMV infection f

184 t were included in the analysis, 57 patients received liposomal bupivacaine, 55 patients received sim

185 ikely source of the input, this subfield has received little attention.

186 een dietary patterns and KOA progression has received little research attention.

187 rent from 0; p=0.351 in the patients who had received <15 doses (n=34), and -0.0135+/-0.1332 (not sig

188 ents enrolled, 153 were randomly assigned to receive luspatercept and 76 to receive placebo; the base

189 Among those who received LVADs, women (aOR, 1.78 [1.38-2.30]), patients

190 of women with severe preeclampsia/eclampsia received magnesium sulphate and 67% with antepartum haem

191 where patients with limited health insurance receive maintenance dialysis has been lacking.

192 nd 12,813 [67%] with a chronic disease), 31% received mechanical ventilation, 19% had shock, and 588

193 In patients at increased cardiovascular risk receiving metformin-based background therapy, specific G

194 ssissippiensis) are apex predators that have received minimal attention within urban areas.

195 Patients receiving mixed care were also analyzed based on percent

196 ess were randomly assigned in a 2:1 ratio to receive monthly subcutaneous injections of evolocumab (4

197 ally catalysed DCC platforms have started to receive more interest in this area.

198 aptic patterns usually involve some partners receiving more synapses than others.

199 We randomized 100 healthy adults to receive morphine versus placebo after two nights of undi

200 h postthrombotic femoral veins and those who received multiple stents were characterized by the highe

201 are Providers (hereafter, the Coalition) has received national attention as a promising superutilizer

202 hed in a 1:3 ratio with control patients who received new devices implanted in Canada.

203 Of the patients receiving NGM282 1 mg or 3 mg, 25% and 42%, respectively

204 All patients received nivolumab alone with subsequent arm allocation

205 ients with previously treated advanced NSCLC received nivolumab monotherapy (3 mg/kg every 2 weeks).

206 women were enrolled and randomly assigned to receive no tumour bed boost (n=605) or tumour bed boost

207 The control group received no treatment.

208 Cancer patients receive numerous medications not only to combat cancer b

209 les of sofosbuvir-velpatasvir (P < .001) and receiving OAT at week 24 (P = .01).

210 were pooled and analysed, in which patients received one of six CBMPs containing regulatory T cells,

211 People with HIV should receive ongoing HIV prevention counselling and partner s

212 The control group received only routine outpatient care.

213 s and associated factors in a cohort of PWID receiving opioid agonist therapy (OAT).

214 DFEs) were assessed for established patients receiving optical coherence tomography (OCT)-guided intr

215 To receive optimal medical care and achieve desired outcome

216 assess the cardiac failure risk in patients receiving osimertinib by evaluating the available data.

217 ents had improvement of index symptoms after receiving palliative liver RT with median response durat

218 not initiate treatment, 8 (1.8%) of 443 who received partial treatment, and 1 (0.2%) of 517 who comp

219 ic yield and increase the number of patients receiving personalized care and counselling on prognosis

220 300 mg S44819 twice a day, and 193 (33%) to receive placebo twice a day.

221 e assigned to receive allopurinol and 263 to receive placebo.

222 80 allocated to receive vitamin K and 79 to receive placebo.

223 y assigned to receive luspatercept and 76 to receive placebo; the baseline characteristics of the pat

224 ns, whereas 1369 patients in the control arm received placebo or standard care.

225 who received SNF472 and 5 patients (6%) who received placebo.

226 patients received simple bupivacaine and 52 received placebo.

227 - 0.11 mg/kg/min, P < 0.05) than in subjects receiving placebo, and it was associated with a signific

228 has been known for decades, patients with RA receive poorer primary and secondary CVD preventive care

229 Comparisons were made among patients receiving pre-LT LRT with (n = 802) and without (n = 263

230 In the intervention arm, 1354 patients received prebiotic or symbiotic preparations, whereas 13

231 Patients who received pretransplant dialysis treatment in a state wit

232 abase was used to identify adults in England receiving primary antireflux surgery for GERD in 2000 to

233 years: body mass index: 31 +/- 1 kg m(-2) ) received primed continuous l-[ring-(2) H(5) ]phenylalani

234 All patients (100%) received prior ICIs targeting the PD-1 pathway.

235 an age, 55 years; range, 30-88 years; 11 had received prior systemic therapy).

236 All patients receiving PRRT using the fast-infusion protocol were inc

237 Among 101 patients, 41 received R-Mono and 60 had R-CHOP.

238 er in clusters receiving rfMDA than in those receiving RACD (adjusted incidence rate ratio 0.52 [95%

239 that received rfMDA plus RAVC than in those receiving RACD only (0.26 [0.10-0.68], p=0.006).

240 Additionally, 1 of 12 patients who received radioiodine for differentiated thyroid carcinom

241 difference, +26 mum) at baseline than those receiving ranibizumab, which were not significantly diff

242 porine A-treated animals compared with those receiving rapamycin.

243 % CI 0.16-0.88], p=0.009), lower in clusters receiving RAVC than in those that did not (0.48 [0.16-0.

244 End-organ impairment has received relatively little research attention as a possi

245 Patients who received reused devices in this program were matched in

246 -0.80], p=0.002), and lower in clusters that received rfMDA plus RAVC than in those receiving RACD on

247 e incidence of malaria was lower in clusters receiving rfMDA than in those receiving RACD (adjusted i

248 Of the 200 randomized, 98 received RT and 102 LBT.

249 IV steroid-refractory aGVHD were eligible to receive ruxolitinib orally, starting at 5 mg twice daily

250 In acutely ill children receiving rWGS for diagnosis of genetic disease, we prop

251 we find that a subset of neurons in the ACC receives S1 inputs, and activation of the S1 axon termin

252 n partnership with a central laboratory that receives samples from approximately 1300 dialysis facili

253 non-allelic (e.g. pseudogene) sequences have received scant scrutiny and, crucially, remain to be add

254 Patients receiving second-line chemotherapy followed by resection

255 Forty-seven patients received selatogrel 8 mg (n = 24) or 16 mg (n = 23) foll

256 particular health risks faced by individuals receiving sex steroid treatment.

257 s, after free gingival grafts (FGG) harvest, received sham application of electrotherapy.

258 eases the signal-to-noise ratio (SNR) of the received signal.

259 quire any information about the phase of the received signal.

260 controls, patients in the intervention group received significantly lower daily doses of everolimus a

261 received liposomal bupivacaine, 55 patients received simple bupivacaine and 52 received placebo.

262 Death occurred in 7 patients (4%) who received SNF472 and 5 patients (6%) who received placebo

263 Of the 418 matched patients, 209 received SoC and 209 received dalbavancin.

264 tients on the Beat AML sub-studies and those receiving SOC (induction with cytarabine + daunorubicin

265 limitations of the three suggested paths for receiving specific 5,10-diheterotruxene derivatives beca

266 Of the patients, 71.5% (186/260) received sRT: 38.2% (71/186) to the fossa only, 49.4% (9

267 Patients 10 to 17 years of age who had received stable lipid-lowering treatment for at least 4

268 group), and controls with drug-sensitive TB received standard dose (5 mg/kg/day).

269 engthened male circumcision services, and 15 received standard of care.

270 Patients in the current report received standard taxane- and anthracycline-based neoadj

271 th fbRFs are located in cortical layers that receive strong feedback projections and are absent in th

272 the patients in the placebo group were still receiving supplemental oxygen.

273 All ARTI diagnoses but influenza predicted receiving systemic steroids.

274 One hundred percent and 99% of patients received the assigned intervention in the PVI-alone and

275 the physician who performed the implantation received the largest payment.

276 Thus far, eosinophilic esophagitis (EoE) has received the most focus, leading to significant advances

277 the 505 intervention participants, 491 (97%) received the Step it Up intervention.

278 station with a live singleton pregnancy, and receiving the diagnosis of undifferentiated gastric carc

279 e rate ratios (IRRs) were compared for units receiving the surface coating application and for contem

280 itis compared to those patients that did not receive them and they may prove beneficial in the most s

281 gents to prevent recurrence, but could still receive these agents to prevent or treat osteoporosis.

282 and compared with Myeloma IX, more patients received thromboprophylaxis (80.5% vs 22.3%) with lower

283 The barrel-free zone receives topographically ordered input from the lower li

284 for 35 849 T2DM kidney disease patients who received transplant between 2000 and 2016 and survived t

285 ndividuals with AF may be unaware and do not receive treatment that could prevent a stroke.

286 splantation, and in the treosulfan group 221 received treatment and 220 transplanation).

287 nts were enrolled (240 in the busulfan group received treatment and transplantation, and in the treos

288 Those still receiving treatment at 1 year, including patients percei

289 ort study, including all patients > 18 years receiving treatment for culture-confirmed, drug-sensitiv

290 attractive adjunctive strategy for patients receiving Treg cell therapeutics.

291 The patient then received tumor removal surgery through lateral orbitotom

292 our age-descending groups, randomized 2:1 to receive two doses of TAK-003 or placebo 90 days apart.

293 Rats received two 30-psi (~ 207-kPa) blasts 24 h apart or wer

294 ogy Group performance status of 0-2, and had received up to two previous lines of chemotherapy for me

295 t in 57 (28%) infants, particularly in those receiving urWGS (p = 0.0001) and positive tests (p < 0.0

296 Eighteen recipients received uteri from living donors and 2 from deceased do

297 new positive-pressure ventilation, and 19.7% received vasopressors.

298 tion-to-treat analysis, with 80 allocated to receive vitamin K and 79 to receive placebo.

299 he global "greening up." These programs have received worldwide attention due to its contribution tow

300 Unexpectedly, the mice receiving WSB/EiJ microbiota increased adiposity but dec